These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7720059)

  • 1. Accessory signals for growth and differentiation of human T lymphocytes.
    Meuer SC; Samstag Y; Schraven B
    Cancer Surv; 1995; 22():63-73. PubMed ID: 7720059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.
    Suthanthiran M
    Transplant Proc; 1987 Feb; 19(1 Pt 1):336-7. PubMed ID: 2908550
    [No Abstract]   [Full Text] [Related]  

  • 4. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.
    Espagnolle N; Depoil D; Zaru R; Demeur C; Champagne E; Guiraud M; Valitutti S
    Int Immunol; 2007 Mar; 19(3):239-48. PubMed ID: 17220479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging paradigms of T-cell co-stimulation.
    Kroczek RA; Mages HW; Hutloff A
    Curr Opin Immunol; 2004 Jun; 16(3):321-7. PubMed ID: 15134781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptors and ligands implicated in human T cell costimulatory processes.
    Leitner J; Grabmeier-Pfistershammer K; Steinberger P
    Immunol Lett; 2010 Feb; 128(2):89-97. PubMed ID: 19941899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of non-adhesive T-cell-accessory cell interactions in the induction of T-cell proliferative hyporesponsiveness.
    Ibrahim MA; Chain BM; Katz DR
    Immunology; 1994 Apr; 81(4):521-31. PubMed ID: 7913693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterned surfaces as tools to study ligand recognition and synapse formation by T cells.
    Irvine DJ; Doh J; Huang B
    Curr Opin Immunol; 2007 Aug; 19(4):463-9. PubMed ID: 17616382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An 'alternative' pathway of T cell activation.
    Meuer SC; Schraven B; Samstag Y
    Int Arch Allergy Immunol; 1994 Jul; 104(3):216-21. PubMed ID: 7913355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracellular events in T lymphocyte's activation].
    Cianga C; Cianga P
    Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):229-34. PubMed ID: 12638265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide.
    Matsuoka T; Kohrogi H; Ando M; Nishimura Y; Matsushita S
    J Immunol; 1996 Dec; 157(11):4837-43. PubMed ID: 8943386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of antigen-specific T cell responses by Leishmania major excreted factor: inhibition of activation signals linked to the T cell antigen receptor and interleukin 2 receptor.
    Isakov N; Tamir A; el-On J
    Isr J Med Sci; 1994 Sep; 30(9):673-9. PubMed ID: 8088978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alloimmune response and effector mechanisms of allograft rejection.
    Arakelov A; Lakkis FG
    Semin Nephrol; 2000 Mar; 20(2):95-102. PubMed ID: 10746853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation.
    Leitenberg D; Balamuth F; Bottomly K
    Semin Immunol; 2001 Apr; 13(2):129-38. PubMed ID: 11308296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.